Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study.

ABSTRACT:

Background

Although current osteoporosis management guidelines recommend use of pharmacologic treatment after hip fracture, the care of such patients has been suboptimal. The objective of this cross-national study was to quantify the use of and adherence to osteoporosis medication after hip fracture in 3 countries with different healthcare systems—the United States, Korea, and Spain.

Methods

In 3 cohorts of patients aged ≥65 years hospitalized for hip fracture, we calculated the proportion receiving ≥1 osteoporosis drug after discharge. Adherence to osteoporosis treatment was measured as the proportion of days covered (PDC) during the first year after the hip fracture.

Results

We identified 86,202 patients with a hip fracture: 4704 (US Medicare), 6700 (US commercial),

SUBMITTER: Kim SC 

PROVIDER: S-EPMC4414898 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature